NewsRx

Search our medical news database

Arthritis

Bentley Announces Product Approvals in Spain and Ireland

Published in Medical Letter on the CDC and FDA, November 18th, 2007

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company focused on advanced drug delivery technologies and generic pharmaceutical products, announced five generic product approvals from the Spanish Ministry of Health and an approval for simvastatin from the Irish Medicines Board.

In Spain, Laboratorios Davur, as well as two other Bentley subsidiaries, Laboratorios Rimafar and Laboratorios Belmac, received approval for alendronate weekly. Alendronate is used in the treatment of osteoporosis and bone loss, and is the generic version of Fosamax(R), which is currently marketed by Merck & Company, Inc. According to IMS Health, Inc., annual brand sales...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook